To study the clinical efficacy of microsurgical treatment of basal ganglia intracerebral hemorrhage with small incision via transsylvian transinsular approach.

A total of 110 patients with basal ganglia intracerebral hemorrhage admitted to the Department of Neurosurgery of Gaomi People’s Hospital from February 2018 to February 2020 were reviewed. According to different treatment methods, they were divided into study group and control group, with 55 patients in each group. The control group was treated with traditional craniotomy, and the study group was treated with microsurgery small incision via transsylvian transinsular approach. The postoperative recovery and postoperative complications of the two groups were analyzed.

The incidence of postoperative gastrointestinal bleeding, pneumonia, rebleeding and postoperative hydrocephalus in the study group were significantly lower than those in the control group (P<0.05). In the study group, 52 patients were awake 48 h after operation and 3 patients were awake within 2 weeks; In the control group, 39 patients were awake 48 h after operation, 13 patients were awake within 2 weeks, and 3 patients were in long-term coma; The difference was statistically significant (P<0.05). The severe disability rate (3.64%) in the study group was significantly lower than that in the control group (23.64%), and the recovery rate (96.36%) was significantly higher than that in the control group (76.36%) (P<0.05).

Microsurgical treatment of basal ganglia intracerebral hemorrhage with small incision via transsylvian transinsular approach is effective, safe and reliable. It can effectively reduce postoperative complications and improve the quality of life of patients. Therefore, it can be considered as the first choice for basal ganglia intracerebral hemorrhage.